Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Ahn, Kwang Woo  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Arora, M., Hemmer, M.T., Ahn, K.Woo, Klein, J.P., Cutler, C.S., Urbano-Ispizua, A., Couriel, D.R., Alousi, A.M., Gale, R.Peter, Inamoto, Y., et al. (2014). CIBMTR Chronic GVHD Risk Score Predicts Mortality in an Independent Validation Cohort.Biol Blood Marrow Transplant.
D
Deol, A., Sengsayadeth, S., Ahn, K.Woo, Wang, H.-L., Aljurf, M., Antin, J.Harry, Battiwalla, M., Bornhäuser, M., Cahn, J.-Y., Camitta, B., et al. (2016). Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.Cancer.
I
Dandoy, C.E., Kim, S., Chen, M., Ahn, K.Woo, Ardura, M.I., Brown, V., Chhabra, S., Díaz, M.Ángel, Dvorak, C., Farhadfar, N., et al. (2020). Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant.Jama Netw Open3, e1918668.
O
Lund, T.C., Ahn, K.Woo, Tecca, H.R., Hilgers, M.V., Abdel-Azim, H., Abraham, A., Díaz, M.Ángel, Badawy, S.M., Broglie, L., Brown, V., et al. (2018). Outcomes After Second Hematopoietic Cell Transplant for Children and Young Adults with Relapsed Acute Leukemia.Biol Blood Marrow Transplant.
Jacobsohn, D.A., Loken, M.R., Fei, M., Adams, A., Brodersen, L.Eidenschin, Logan, B.R., Ahn, K.Woo, Shaw, B.E., Kletzel, M., Olszewski, M., et al. (2018). Outcomes of measurable residual disease in pediatric acute myeloid leukemia pre- and post-hematopoietic stem cell transplant: validation of difference from normal flow cytometry with chimerism studies and Wilms tumor 1 gene expression.Biol Blood Marrow Transplant.
S
Naik, S., Riches, M., Hari, P., Soyoung, K., Chen, M., Bachier, C., Shaughnessy, P., Hill, J., Ljungman, P., Battiwalla, M., et al. (2019). Survival Outcomes of Allogeneic Hematopoietic Cell Transplants with EBV positive or EBV negative Post Transplant Lymphoproliferative Disorder (PTLD), A CIBMTR Study.Transpl Infect Dise13145.